Autonomix Medical (AMIX) Competitors

Autonomix Medical logo
$0.90 -0.14 (-13.56%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$0.90 0.00 (-0.44%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AMIX vs. NDRA, NMTC, TNON, NVNO, and BDMD

Should you buy Autonomix Medical stock or one of its competitors? Autonomix Medical's main competitors and comparable companies include ENDRA Life Sciences (NDRA), NeuroOne Medical Technologies (NMTC), Tenon Medical (TNON), enVVeno Medical (NVNO), and Baird Medical Investment (BDMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Autonomix Medical compare to ENDRA Life Sciences?

Autonomix Medical (NASDAQ:AMIX) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Autonomix Medical presently has a consensus target price of $42.00, suggesting a potential upside of 4,571.86%. ENDRA Life Sciences has a consensus target price of $25.00, suggesting a potential upside of 617.36%. Given Autonomix Medical's higher probable upside, equities analysts plainly believe Autonomix Medical is more favorable than ENDRA Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
ENDRA Life Sciences
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

ENDRA Life Sciences is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$15.09N/A
ENDRA Life SciencesN/AN/A-$7.03M-$5.30N/A

In the previous week, ENDRA Life Sciences had 2 more articles in the media than Autonomix Medical. MarketBeat recorded 4 mentions for ENDRA Life Sciences and 2 mentions for Autonomix Medical. Autonomix Medical's average media sentiment score of 0.00 beat ENDRA Life Sciences' score of -0.75 indicating that Autonomix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ENDRA Life Sciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are owned by institutional investors. 5.5% of Autonomix Medical shares are owned by insiders. Comparatively, 10.0% of ENDRA Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Autonomix Medical has a beta of -0.7, indicating that its stock price is 170% less volatile than the broader market. Comparatively, ENDRA Life Sciences has a beta of -0.07, indicating that its stock price is 107% less volatile than the broader market.

ENDRA Life Sciences' return on equity of -178.84% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -191.88% -157.15%
ENDRA Life Sciences N/A -178.84%-121.58%

Summary

ENDRA Life Sciences beats Autonomix Medical on 7 of the 10 factors compared between the two stocks.

How does Autonomix Medical compare to NeuroOne Medical Technologies?

Autonomix Medical (NASDAQ:AMIX) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

Autonomix Medical has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -71.50%. NeuroOne Medical Technologies' return on equity of -128.12% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -191.88% -157.15%
NeuroOne Medical Technologies -71.50%-128.12%-86.34%

Autonomix Medical presently has a consensus price target of $42.00, suggesting a potential upside of 4,571.86%. NeuroOne Medical Technologies has a consensus price target of $7.33, suggesting a potential upside of 1,024.57%. Given Autonomix Medical's higher possible upside, equities research analysts clearly believe Autonomix Medical is more favorable than NeuroOne Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
NeuroOne Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

NeuroOne Medical Technologies has higher revenue and earnings than Autonomix Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$15.09N/A
NeuroOne Medical Technologies$12.10M0.49-$3.61M-$0.95N/A

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 5.5% of Autonomix Medical shares are owned by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Autonomix Medical has a beta of -0.7, suggesting that its share price is 170% less volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.95, suggesting that its share price is 5% less volatile than the broader market.

In the previous week, Autonomix Medical had 2 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 2 mentions for Autonomix Medical and 0 mentions for NeuroOne Medical Technologies. Autonomix Medical's average media sentiment score of 0.00 equaled NeuroOne Medical Technologies'average media sentiment score.

Company Overall Sentiment
Autonomix Medical Neutral
NeuroOne Medical Technologies Neutral

Summary

NeuroOne Medical Technologies beats Autonomix Medical on 10 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to Tenon Medical?

Autonomix Medical (NASDAQ:AMIX) and Tenon Medical (NASDAQ:TNON) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, Autonomix Medical had 1 more articles in the media than Tenon Medical. MarketBeat recorded 2 mentions for Autonomix Medical and 1 mentions for Tenon Medical. Autonomix Medical's average media sentiment score of 0.00 equaled Tenon Medical'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tenon Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 5.5% of Autonomix Medical shares are held by insiders. Comparatively, 17.7% of Tenon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Tenon Medical has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$15.09N/A
Tenon Medical$3.94M0.61-$12.56M-$36.27N/A

Autonomix Medical has a net margin of 0.00% compared to Tenon Medical's net margin of -305.10%. Autonomix Medical's return on equity of -191.88% beat Tenon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -191.88% -157.15%
Tenon Medical -305.10%-907.60%-152.12%

Autonomix Medical has a beta of -0.7, suggesting that its stock price is 170% less volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

Autonomix Medical currently has a consensus price target of $42.00, indicating a potential upside of 4,571.86%. Given Autonomix Medical's higher probable upside, equities research analysts plainly believe Autonomix Medical is more favorable than Tenon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tenon Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Tenon Medical beats Autonomix Medical on 6 of the 11 factors compared between the two stocks.

How does Autonomix Medical compare to enVVeno Medical?

enVVeno Medical (NASDAQ:NVNO) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

enVVeno Medical has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -0.7, meaning that its share price is 170% less volatile than the broader market.

Autonomix Medical has a consensus target price of $42.00, indicating a potential upside of 4,571.86%. Given Autonomix Medical's higher possible upside, analysts plainly believe Autonomix Medical is more favorable than enVVeno Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
enVVeno Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

enVVeno Medical's return on equity of -70.33% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
enVVeno MedicalN/A -70.33% -63.60%
Autonomix Medical N/A -191.88%-157.15%

34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 14.8% of enVVeno Medical shares are owned by company insiders. Comparatively, 5.5% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

enVVeno Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
enVVeno MedicalN/AN/A-$19.47M-$17.55N/A
Autonomix MedicalN/AN/A-$16.72M-$15.09N/A

In the previous week, Autonomix Medical had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for Autonomix Medical and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 0.61 beat Autonomix Medical's score of 0.00 indicating that enVVeno Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
enVVeno Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

enVVeno Medical beats Autonomix Medical on 8 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to Baird Medical Investment?

Autonomix Medical (NASDAQ:AMIX) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Autonomix Medical has a beta of -0.7, meaning that its share price is 170% less volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -0.98, meaning that its share price is 198% less volatile than the broader market.

Baird Medical Investment's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -191.88% -157.15%
Baird Medical Investment N/A N/A N/A

Baird Medical Investment has higher revenue and earnings than Autonomix Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$15.09N/A
Baird Medical Investment$22.54M0.17N/AN/AN/A

Autonomix Medical currently has a consensus price target of $42.00, indicating a potential upside of 4,571.86%. Given Autonomix Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Autonomix Medical is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 5.5% of Autonomix Medical shares are owned by insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Autonomix Medical and Autonomix Medical both had 2 articles in the media. Autonomix Medical's average media sentiment score of 0.00 beat Baird Medical Investment's score of -0.02 indicating that Autonomix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Baird Medical Investment
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Autonomix Medical and Baird Medical Investment tied by winning 5 of the 10 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMIX vs. The Competition

MetricAutonomix MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.07M$6.00B$7.75B$11.70B
Dividend YieldN/A1.69%2.48%4.66%
P/E Ratio-0.0638.2132.5328.82
Price / SalesN/A5.437.975.37
Price / CashN/A23.7921.0521.90
Price / Book0.134.014.263.50
Net Income-$16.72M$143.06M$3.51B$394.12M
1 Month Performance-65.02%-8.30%-10.58%-12.04%
1 Year Performance-95.80%-4.45%-4.79%-11.42%

Autonomix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMIX
Autonomix Medical
2.1669 of 5 stars
$0.90
-13.6%
$42.00
+4,571.9%
-95.7%$1.07MN/AN/A11
NDRA
ENDRA Life Sciences
2.0487 of 5 stars
$4.74
-0.7%
$25.00
+427.9%
-38.2%$7.15MN/AN/A11
NMTC
NeuroOne Medical Technologies
2.7 of 5 stars
$0.76
-2.7%
$7.33
+870.0%
-81.9%$7.08M$12.10MN/A18
TNON
Tenon Medical
0.7906 of 5 stars
$1.75
+0.3%
N/A-97.5%$4.68M$3.94MN/A26
NVNO
enVVeno Medical
1.4107 of 5 stars
$6.52
+1.1%
N/A-53.5%$4.48MN/AN/A33

Related Companies and Tools


This page (NASDAQ:AMIX) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners